PDE4A and familial dilated cardiomyopathy: Although targeting the elevated expression of PDE4D by the PDE4 inhibitor was effective in treating DCM in the HFD-fed mice, the PDE4 inhibitor has low therapeutic index because of systemic side effects including nausea, emesis, diarrhoea and headache (Phillips, 2020).